SCHEMBL4907503

SCHEMBL4907503

Nc1cc(Cl)cnc1Oc1cccnc1CN1CCOCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.40
NPC1 O15118 3/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
METAP2 P50579 1/20 0.40
PAX8 Q06710 1/20 0.40
KDM4E B2RXH2 2/20 0.39
HIF1A Q16665 1/20 0.39
SYK P43405 1/20 0.38
GRM4 Q14833 2/20 0.38
HTT P42858 4/20 0.37
RECQL P46063 1/20 0.37
EGLN1 Q9GZT9 1/20 0.37
NPSR1 Q6W5P4 2/20 0.37
TP53 P04637 4/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
LMNA P02545 2/20 0.37
MAPT P10636 2/20 0.37
MITF O75030 1/20 0.37
ALOX15 P16050 1/20 0.37
MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4902941 0.77 CCR2 (0.66)
SCHEMBL4910086 0.76 SLC6A4 (0.38)
SCHEMBL4906323 0.75 CCR2 (0.47) L3MBTL1MAPTTDP1MEN1KMT2A
SCHEMBL4909567 0.74 CYP3A4 (0.41) RAB9ANPC1KDM4ESMN1; SMN2LMNA
SCHEMBL4910281 0.72 CCR2 (0.53) L3MBTL1SMN1; SMN2LMNATSHR
SCHEMBL16742708 0.70 HTT (0.43) RAB9ANPC1L3MBTL1METAP2KDM4E
SCHEMBL4911233 0.69 ALOX5AP (0.38) L3MBTL1KDM4ESMN1; SMN2LMNAMAPT
SCHEMBL16742705 0.69 EGLN1 (0.40) RAB9ANPC1L3MBTL1METAP2PAX8
SCHEMBL10035128 0.68 EGLN1 (0.60) HIF1AEGLN1ALDH1A1MEN1KMT2A
SCHEMBL14006333 0.68 CYP1A2 (0.49) HTTSMN1; SMN2LMNAMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080293720-A1 Pyridinyl Sulfonamide Modulators of Chemokine Receptors GLAXO GROUP LIMITED (GB) 2008-11-27 US disclosed
US-20080293720-A1 Pyridinyl Sulfonamide Modulators of Chemokine Receptors GLAXO GROUP LIMITED (GB) 2008-11-27 US disclosed
US-20080293720-A1 Pyridinyl Sulfonamide Modulators of Chemokine Receptors GLAXO GROUP LIMITED (GB) 2008-11-27 US disclosed
WO-2007067875-A2 PYRIDINYL SULFONAMIDE MODULATORS OF CHEMOKINE RECEPTORS GLAXO GROUP LIMTED (GB) 2007-06-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293720-A1 Pyridinyl Sulfonamide Modulators of Chemokine Receptors CCR2, CCR1, CCRL2 RAB9A 3618/4885NPC1 1838/4885L3MBTL1 4868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.